R&D
Gene Therapy of ANLBIO
Gene therapy for neurodegenerative diseases targeting microRNA and others
-
DNA Sequence
01 -
AAV vector as a delivering vehicle
02 -
Single injection
03 -
Long-lasting effect
04
AAV Delivery Platform of ANLBIO
Safe arrival of transgenes into nuclei is all about gene therapy drugs
ANLBIO answers tocommercial challenges of gene therapy modalities with an innovative
delivery platform of viral vectors including AAV
-
Enhanced Random Mutagenesis System (ERMS)
01 -
Mutation of capsid protein at multiple position
02 -
Revamped screening by barcode & deep sequencing
03 -
Capsid protein library
04